BioCentury | Oct 1, 2012
Company News

Repligen management update

...Neurology, Autoimmune, Gastrointestinal Hired: Jonathan Lieber as CFO and treasurer, formerly CFO and treasurer of Xcellerex Inc....
BioCentury | Jun 25, 2012
Company News

General Electric sales and marketing update

...GE's Xcellerex Inc. company launched its XDR-10 single-use bioreactor worldwide for benchtop use. The company said XDR-10...
...clinical and commercial manufacture of biotherapeutics, vaccines and other biologics. GE's GE Healthcare unit acquired Xcellerex...
BioCentury | May 14, 2012
Company News

Xcellerex, General Electric deal

...completed its acquisition of biomanufacturing company Xcellerex. Details were not disclosed (see BioCentury, March 12). Xcellerex Inc....
BioCentury | Mar 12, 2012
Company News

Xcellerex, General Electric deal

...GE's GE Healthcare unit will acquire biomanufacturing company Xcellerex. GE said the acquisition will allow it...
...Xcellerex. Xcellerex said it recorded 2011 revenues of about $50 million. Details were not disclosed. Xcellerex Inc....
BioCentury | Apr 11, 2011
Clinical News

XRX-001: Phase I data

...vs. 30, p<0.001). Adverse events included mild pain, tenderness and itching at the injection site. Xcellerex Inc....
BioCentury | Sep 20, 2010
Finance

Venture and Hedge Fund Tracks

...NASDAQ:TRBN) and was its chairman and CEO. Zakrzewski was president and CEO of biomanufacturing play Xcellerex Inc....
BioCentury | Aug 30, 2010
Company News

Xcellerex, SK Chemicals Co. Ltd. deal

...SK Chemicals for undisclosed indications using Xcellerex's FlexFactory biomanufacturing platform. Further terms were not disclosed. Xcellerex Inc....
BioCentury | Apr 19, 2010
Company News

Xcellerex management update

Xcellerex Inc. , Marlborough, Mass. Business: Biomanufacturing Hired: Guy Broadbent as president, CEO and a director, formerly SVP of corporate development at Thermo Fisher Scientific Inc. ; he succeeds Joseph Zakrzewski, who will remain as chairman...
BioCentury | Dec 7, 2009
Company News

Amarin board of directors update

...Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Metabolic, Cardiovascular, Neurology Appointed: Joseph Zakrzewski, CEO of Xcellerex Inc....
BioCentury | Dec 3, 2009
Company News

Amarin withdraws AMR101 MAA for Huntington's

...also named Joseph Zakrzewski as executive chairman, effective Jan. 1. Zakrzewski is currently CEO of Xcellerex...
Items per page:
1 - 10 of 24
BioCentury | Oct 1, 2012
Company News

Repligen management update

...Neurology, Autoimmune, Gastrointestinal Hired: Jonathan Lieber as CFO and treasurer, formerly CFO and treasurer of Xcellerex Inc....
BioCentury | Jun 25, 2012
Company News

General Electric sales and marketing update

...GE's Xcellerex Inc. company launched its XDR-10 single-use bioreactor worldwide for benchtop use. The company said XDR-10...
...clinical and commercial manufacture of biotherapeutics, vaccines and other biologics. GE's GE Healthcare unit acquired Xcellerex...
BioCentury | May 14, 2012
Company News

Xcellerex, General Electric deal

...completed its acquisition of biomanufacturing company Xcellerex. Details were not disclosed (see BioCentury, March 12). Xcellerex Inc....
BioCentury | Mar 12, 2012
Company News

Xcellerex, General Electric deal

...GE's GE Healthcare unit will acquire biomanufacturing company Xcellerex. GE said the acquisition will allow it...
...Xcellerex. Xcellerex said it recorded 2011 revenues of about $50 million. Details were not disclosed. Xcellerex Inc....
BioCentury | Apr 11, 2011
Clinical News

XRX-001: Phase I data

...vs. 30, p<0.001). Adverse events included mild pain, tenderness and itching at the injection site. Xcellerex Inc....
BioCentury | Sep 20, 2010
Finance

Venture and Hedge Fund Tracks

...NASDAQ:TRBN) and was its chairman and CEO. Zakrzewski was president and CEO of biomanufacturing play Xcellerex Inc....
BioCentury | Aug 30, 2010
Company News

Xcellerex, SK Chemicals Co. Ltd. deal

...SK Chemicals for undisclosed indications using Xcellerex's FlexFactory biomanufacturing platform. Further terms were not disclosed. Xcellerex Inc....
BioCentury | Apr 19, 2010
Company News

Xcellerex management update

Xcellerex Inc. , Marlborough, Mass. Business: Biomanufacturing Hired: Guy Broadbent as president, CEO and a director, formerly SVP of corporate development at Thermo Fisher Scientific Inc. ; he succeeds Joseph Zakrzewski, who will remain as chairman...
BioCentury | Dec 7, 2009
Company News

Amarin board of directors update

...Amarin Corp. plc (NASDAQ:AMRN), Dublin, Ireland Business: Metabolic, Cardiovascular, Neurology Appointed: Joseph Zakrzewski, CEO of Xcellerex Inc....
BioCentury | Dec 3, 2009
Company News

Amarin withdraws AMR101 MAA for Huntington's

...also named Joseph Zakrzewski as executive chairman, effective Jan. 1. Zakrzewski is currently CEO of Xcellerex...
Items per page:
1 - 10 of 24